RepliCel Life Sciences Salute del bilancio
Salute finanziaria criteri di controllo 0/6
RepliCel Life Sciences has a total shareholder equity of CA$-5.0M and total debt of CA$1.2M, which brings its debt-to-equity ratio to -25%. Its total assets and total liabilities are CA$172.7K and CA$5.2M respectively.
Informazioni chiave
-25.0%
Rapporto debito/patrimonio netto
CA$1.24m
Debito
| Indice di copertura degli interessi | n/a |
| Contanti | CA$148.95k |
| Patrimonio netto | -CA$4.98m |
| Totale passività | CA$5.15m |
| Totale attività | CA$172.68k |
Aggiornamenti recenti sulla salute finanziaria
Recent updates
Analisi della posizione finanziaria
Passività a breve termine: REPC.F has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Passività a lungo termine: REPC.F has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: REPC.F has negative shareholder equity, which is a more serious situation than a high debt level.
Riduzione del debito: REPC.F's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Copertura del debito: REPC.F's operating cash flow is negative, therefore debt is not well covered.
Copertura degli interessi: Insufficient data to determine if REPC.F's interest payments on its debt are well covered by EBIT.